infliximab
janssen
['ibd', 'infliximab', 'imab ']
report from ccc 2023: switching to infliximab biosimilar safe for adolescents, young adults with ibd. #cccongress23 #ibd
No. 1–rated independent monthly newspaper providing news and information for 20,000+ gastroenterologists, colorectal surgeons, hepatologists, PAs and NPs.